New research published today in Blood Advances finds that young adult Black patients with acute myeloid leukemia (AML), an aggressive and fast-growing form of blood cancer, were five times more likely than comparable white ...
Jul 5, 2022
0
7
The long-term survival of adolescent and young adult (AYA) acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) survivors was shorter than that of the general population, and the differences persisted for up ...
May 13, 2022
0
5
South Australian scientists have made a significant breakthrough in overcoming drug resistance in acute myeloid leukemia (AML), a rare and devastating blood cancer that kills most patients within a few years.
May 9, 2022
0
49
More effective therapies are needed for acute leukemia, particularly for people over 50 years of age at diagnosis, according to research published today by the Medical Journal of Australia.
Mar 14, 2022
0
2
(HealthDay)—A polygenic score derived from pharmacogenomic evaluation of cytarabine (ara-C) pathway can help personalize treatment for pediatric patients with acute myeloid leukemia (AML), according to a study published ...
Feb 1, 2022
0
5
A new study led by scientists at Sanford Burnham Prebys has shown that the protein RNF5 plays an unusual role in acute myeloid leukemia (AML). Unlike its expected role, marking aberrant proteins for destruction, RNF5 binds ...
Sep 13, 2021
0
86
A new combination of drugs that may have the potential to treat a type of leukemia has been uncovered by a detailed molecular examination of leukemia cells by RIKEN researchers1.
Jun 28, 2021
0
11
(HealthDay)—From 1980 to 2017, there was improvement in survival for acute myeloid leukemia (AML) in all age groups, except for those aged ≥70 years, according to a study published in the June 15 issue of Cancer.
Jun 10, 2021
0
1
Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in Blood Advances, a journal of ...
May 5, 2021
0
13
A McMaster stem cell research team has made an important early step in developing a new class of therapeutics for patients with a deadly blood cancer.
Feb 16, 2021
0
10
